Philips launches ECG AI marketplace to streamline cardiac diagnostics
Philips (NYSE: PHG) has unveiled a new ECG AI marketplace designed to centralize access to multiple AI-powered diagnostic tools for cardiac care teams. The platform
Philips (NYSE: PHG) has unveiled a new ECG AI marketplace designed to centralize access to multiple AI-powered diagnostic tools for cardiac care teams. The platform
UroMems has received FDA investigational device exemption (IDE) approval to launch its SOPHIA2 clinical trial evaluating the UroActive smart implant for stress urinary incontinence (SUI)
Nuwellis has ended its REVERSE HF randomized trial comparing ultrafiltration with IV loop diuretics in hospitalized heart failure patients after enrolling 167 participants since 2022.
NanoVibronix announced agreements to raise up to $50 million through the sale of Series H convertible preferred stock to an institutional investor. The initial closings,
Hyperfine announced its first commercial sales of the next-generation Swoop portable MRI system, powered by proprietary Optive AI software, to two leading hospitals in the
Stay ahead in MedTech with industry updates, breakthroughs, and expert
insights—delivered straight to your inbox.
© 2025 MEDWIRE.AI. All rights reserved. MEDWIRE.AI is a trusted source for MedTech news and insights. Our website content and services are for informational purposes only. MEDWIRE.AI does not provide medical advice, diagnosis, or treatment.
